Loading…

Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study

Background and Aims: Laparoscopic radio-frequency ablation (L-RFA) for hepatocellular carcinoma (HCC) is used for unresectable tumors, with difficult location, unfitted for a percutaneous ablation technique. L-RFA has a high incidence of local recurrence. Even if intraoperative-ultrasound is standar...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastrointestinal and liver diseases : JGLD 2019-12, Vol.28 (4), p.457-462
Main Authors: Bartoș, Adrian, Bartos, Dana, Spârchez, Zeno, Iancu, Ioana, Ciobanu, Lidia, Iancu, Cornel, Breazu, Caius
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c285t-5005a95efe2ee473fb0147981931f22333ad9b6ae54bd08e26251e49a34e06ed3
cites
container_end_page 462
container_issue 4
container_start_page 457
container_title Journal of gastrointestinal and liver diseases : JGLD
container_volume 28
creator Bartoș, Adrian
Bartos, Dana
Spârchez, Zeno
Iancu, Ioana
Ciobanu, Lidia
Iancu, Cornel
Breazu, Caius
description Background and Aims: Laparoscopic radio-frequency ablation (L-RFA) for hepatocellular carcinoma (HCC) is used for unresectable tumors, with difficult location, unfitted for a percutaneous ablation technique. L-RFA has a high incidence of local recurrence. Even if intraoperative-ultrasound is standardized for staging and RFA probe guidance, the role of laparoscopic contrast-enhanced ultrasound (L-CEUS) for the real time monitoring of L-RFA efficacy has not been previously reported. We evaluated in a pilot observational study the efficacy of L-CEUS to assess the necrotic post-ablative area in difficult to treat HCC. Methods: Eight consecutive patients diagnosed with HCC (peripherally located) on liver cirrhosis were referred for L-RFA between May 2016 and December 2018. For L-RFA a SturBurst XL (AngioDinamics®) internally cooled electrode was used, being placed under ultrasound guidance. L-CEUS was used to assess the necrotic post-ablative area. The median follow up period was 18 months. Results: L-CEUS real time monitoring of the L-RFA efficacy indicated residual neoplastic tissue in 4 cases (50%). The procedure was repeated by reinserting the needle in the suspected areas indicated by L-CEUS. Complete tumor ablation was achieved in all treated patients. After a median follow-up of 18 months no recurrence of HCC was observed in 7 patients (87.5%). Conclusions: L-CEUS was a reliable procedure for the immediate assessment of L-RFA efficacy; half of the ablated HCC nodules required a second ablation session. This approach might decrease the local recurrences, but its role must be further investigated in larger cohorts.
doi_str_mv 10.15403/jgld-263
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_15403_jgld_263</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_15403_jgld_263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c285t-5005a95efe2ee473fb0147981931f22333ad9b6ae54bd08e26251e49a34e06ed3</originalsourceid><addsrcrecordid>eNpVkMtOwzAQRS0EEqWw4A-8ZRHwKy92VQUUqaiotOtokkxaV64dHBcpv8RX0gY2rGY0Gp2rewi55eyex4rJh93G1JFI5BkZ8UyJiHPBz4edR1kq1CW56rodY0nC0nREvufQgndd5Vpd0amzwUMXoie7BVthTdfmdHDWbTy02542ztMlgqErvUf65qwOzmu7oa6h_1BLqLVrPH4e0FY9nZQGgnZ2AMywheAqNOZgwNMp-Epbt4dHCpYuyg791_B8jHnXxgX6EQ51f00uGjAd3vzNMVk_P62ms2i-eHmdTuZRJbI4RDFjMeQxNigQVSqbknGV5hnPJW-EkFJCnZcJYKzKmmUoEhFzVDlIhSzBWo7J3S-3OpbpPDZF6_UefF9wVgySi5Pk4ihZ_gBUJXSY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study</title><source>Freely Accessible Science Journals</source><creator>Bartoș, Adrian ; Bartos, Dana ; Spârchez, Zeno ; Iancu, Ioana ; Ciobanu, Lidia ; Iancu, Cornel ; Breazu, Caius</creator><creatorcontrib>Bartoș, Adrian ; Bartos, Dana ; Spârchez, Zeno ; Iancu, Ioana ; Ciobanu, Lidia ; Iancu, Cornel ; Breazu, Caius</creatorcontrib><description>Background and Aims: Laparoscopic radio-frequency ablation (L-RFA) for hepatocellular carcinoma (HCC) is used for unresectable tumors, with difficult location, unfitted for a percutaneous ablation technique. L-RFA has a high incidence of local recurrence. Even if intraoperative-ultrasound is standardized for staging and RFA probe guidance, the role of laparoscopic contrast-enhanced ultrasound (L-CEUS) for the real time monitoring of L-RFA efficacy has not been previously reported. We evaluated in a pilot observational study the efficacy of L-CEUS to assess the necrotic post-ablative area in difficult to treat HCC. Methods: Eight consecutive patients diagnosed with HCC (peripherally located) on liver cirrhosis were referred for L-RFA between May 2016 and December 2018. For L-RFA a SturBurst XL (AngioDinamics®) internally cooled electrode was used, being placed under ultrasound guidance. L-CEUS was used to assess the necrotic post-ablative area. The median follow up period was 18 months. Results: L-CEUS real time monitoring of the L-RFA efficacy indicated residual neoplastic tissue in 4 cases (50%). The procedure was repeated by reinserting the needle in the suspected areas indicated by L-CEUS. Complete tumor ablation was achieved in all treated patients. After a median follow-up of 18 months no recurrence of HCC was observed in 7 patients (87.5%). Conclusions: L-CEUS was a reliable procedure for the immediate assessment of L-RFA efficacy; half of the ablated HCC nodules required a second ablation session. This approach might decrease the local recurrences, but its role must be further investigated in larger cohorts.</description><identifier>ISSN: 1841-8724</identifier><identifier>EISSN: 1842-1121</identifier><identifier>DOI: 10.15403/jgld-263</identifier><language>eng</language><ispartof>Journal of gastrointestinal and liver diseases : JGLD, 2019-12, Vol.28 (4), p.457-462</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c285t-5005a95efe2ee473fb0147981931f22333ad9b6ae54bd08e26251e49a34e06ed3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Bartoș, Adrian</creatorcontrib><creatorcontrib>Bartos, Dana</creatorcontrib><creatorcontrib>Spârchez, Zeno</creatorcontrib><creatorcontrib>Iancu, Ioana</creatorcontrib><creatorcontrib>Ciobanu, Lidia</creatorcontrib><creatorcontrib>Iancu, Cornel</creatorcontrib><creatorcontrib>Breazu, Caius</creatorcontrib><title>Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study</title><title>Journal of gastrointestinal and liver diseases : JGLD</title><description>Background and Aims: Laparoscopic radio-frequency ablation (L-RFA) for hepatocellular carcinoma (HCC) is used for unresectable tumors, with difficult location, unfitted for a percutaneous ablation technique. L-RFA has a high incidence of local recurrence. Even if intraoperative-ultrasound is standardized for staging and RFA probe guidance, the role of laparoscopic contrast-enhanced ultrasound (L-CEUS) for the real time monitoring of L-RFA efficacy has not been previously reported. We evaluated in a pilot observational study the efficacy of L-CEUS to assess the necrotic post-ablative area in difficult to treat HCC. Methods: Eight consecutive patients diagnosed with HCC (peripherally located) on liver cirrhosis were referred for L-RFA between May 2016 and December 2018. For L-RFA a SturBurst XL (AngioDinamics®) internally cooled electrode was used, being placed under ultrasound guidance. L-CEUS was used to assess the necrotic post-ablative area. The median follow up period was 18 months. Results: L-CEUS real time monitoring of the L-RFA efficacy indicated residual neoplastic tissue in 4 cases (50%). The procedure was repeated by reinserting the needle in the suspected areas indicated by L-CEUS. Complete tumor ablation was achieved in all treated patients. After a median follow-up of 18 months no recurrence of HCC was observed in 7 patients (87.5%). Conclusions: L-CEUS was a reliable procedure for the immediate assessment of L-RFA efficacy; half of the ablated HCC nodules required a second ablation session. This approach might decrease the local recurrences, but its role must be further investigated in larger cohorts.</description><issn>1841-8724</issn><issn>1842-1121</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpVkMtOwzAQRS0EEqWw4A-8ZRHwKy92VQUUqaiotOtokkxaV64dHBcpv8RX0gY2rGY0Gp2rewi55eyex4rJh93G1JFI5BkZ8UyJiHPBz4edR1kq1CW56rodY0nC0nREvufQgndd5Vpd0amzwUMXoie7BVthTdfmdHDWbTy02542ztMlgqErvUf65qwOzmu7oa6h_1BLqLVrPH4e0FY9nZQGgnZ2AMywheAqNOZgwNMp-Epbt4dHCpYuyg791_B8jHnXxgX6EQ51f00uGjAd3vzNMVk_P62ms2i-eHmdTuZRJbI4RDFjMeQxNigQVSqbknGV5hnPJW-EkFJCnZcJYKzKmmUoEhFzVDlIhSzBWo7J3S-3OpbpPDZF6_UefF9wVgySi5Pk4ihZ_gBUJXSY</recordid><startdate>20191209</startdate><enddate>20191209</enddate><creator>Bartoș, Adrian</creator><creator>Bartos, Dana</creator><creator>Spârchez, Zeno</creator><creator>Iancu, Ioana</creator><creator>Ciobanu, Lidia</creator><creator>Iancu, Cornel</creator><creator>Breazu, Caius</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20191209</creationdate><title>Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study</title><author>Bartoș, Adrian ; Bartos, Dana ; Spârchez, Zeno ; Iancu, Ioana ; Ciobanu, Lidia ; Iancu, Cornel ; Breazu, Caius</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c285t-5005a95efe2ee473fb0147981931f22333ad9b6ae54bd08e26251e49a34e06ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Bartoș, Adrian</creatorcontrib><creatorcontrib>Bartos, Dana</creatorcontrib><creatorcontrib>Spârchez, Zeno</creatorcontrib><creatorcontrib>Iancu, Ioana</creatorcontrib><creatorcontrib>Ciobanu, Lidia</creatorcontrib><creatorcontrib>Iancu, Cornel</creatorcontrib><creatorcontrib>Breazu, Caius</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of gastrointestinal and liver diseases : JGLD</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bartoș, Adrian</au><au>Bartos, Dana</au><au>Spârchez, Zeno</au><au>Iancu, Ioana</au><au>Ciobanu, Lidia</au><au>Iancu, Cornel</au><au>Breazu, Caius</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study</atitle><jtitle>Journal of gastrointestinal and liver diseases : JGLD</jtitle><date>2019-12-09</date><risdate>2019</risdate><volume>28</volume><issue>4</issue><spage>457</spage><epage>462</epage><pages>457-462</pages><issn>1841-8724</issn><eissn>1842-1121</eissn><abstract>Background and Aims: Laparoscopic radio-frequency ablation (L-RFA) for hepatocellular carcinoma (HCC) is used for unresectable tumors, with difficult location, unfitted for a percutaneous ablation technique. L-RFA has a high incidence of local recurrence. Even if intraoperative-ultrasound is standardized for staging and RFA probe guidance, the role of laparoscopic contrast-enhanced ultrasound (L-CEUS) for the real time monitoring of L-RFA efficacy has not been previously reported. We evaluated in a pilot observational study the efficacy of L-CEUS to assess the necrotic post-ablative area in difficult to treat HCC. Methods: Eight consecutive patients diagnosed with HCC (peripherally located) on liver cirrhosis were referred for L-RFA between May 2016 and December 2018. For L-RFA a SturBurst XL (AngioDinamics®) internally cooled electrode was used, being placed under ultrasound guidance. L-CEUS was used to assess the necrotic post-ablative area. The median follow up period was 18 months. Results: L-CEUS real time monitoring of the L-RFA efficacy indicated residual neoplastic tissue in 4 cases (50%). The procedure was repeated by reinserting the needle in the suspected areas indicated by L-CEUS. Complete tumor ablation was achieved in all treated patients. After a median follow-up of 18 months no recurrence of HCC was observed in 7 patients (87.5%). Conclusions: L-CEUS was a reliable procedure for the immediate assessment of L-RFA efficacy; half of the ablated HCC nodules required a second ablation session. This approach might decrease the local recurrences, but its role must be further investigated in larger cohorts.</abstract><doi>10.15403/jgld-263</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1841-8724
ispartof Journal of gastrointestinal and liver diseases : JGLD, 2019-12, Vol.28 (4), p.457-462
issn 1841-8724
1842-1121
language eng
recordid cdi_crossref_primary_10_15403_jgld_263
source Freely Accessible Science Journals
title Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A46%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laparoscopic%20Contrast-Enhanced%20Ultrasonography%20for%20Real%20Time%20Monitoring%20of%20Laparoscopic%20Radiofrequency%20Ablation%20for%20Hepatocellular%20Carcinoma:%20an%20Observational%20Pilot%20Study&rft.jtitle=Journal%20of%20gastrointestinal%20and%20liver%20diseases%20:%20JGLD&rft.au=Barto%C8%99,%20Adrian&rft.date=2019-12-09&rft.volume=28&rft.issue=4&rft.spage=457&rft.epage=462&rft.pages=457-462&rft.issn=1841-8724&rft.eissn=1842-1121&rft_id=info:doi/10.15403/jgld-263&rft_dat=%3Ccrossref%3E10_15403_jgld_263%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c285t-5005a95efe2ee473fb0147981931f22333ad9b6ae54bd08e26251e49a34e06ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true